SCOPUS 정보 검색 플랫폼

Colloids and Surfaces B: Biointerfaces

Volumn 116, Issue , 2014, Pages 41-48

A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles

(4) Wang, Yan a Ma, Shurong a Xie, Zhongshi a Zhang, Haishan a

a JILIN UNIVERSITY (China)

Author keywords

Combination therapy; Doxorubicin; Drug delivery; Nanoparticles; Paclitaxel

Indexed keywords

BIOLOGICAL EVALUATION; CHARACTERIZATION OF NANOPARTICLES; COMBINATION THERAPY; DOXORUBICIN; MICELLAR NANOPARTICLES; PACLITAXEL; POLYMERIC CARRIERS; SYNERGISTIC COMBINATIONS;

BIODEGRADABLE POLYMERS; CONJUGATED POLYMERS; DRUG DELIVERY;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; DOXORUBICIN; DOXORUBICIN PLUS PACLITAXEL; MICELLAR NANOPARTICLE; NANOPARTICLE; PACLITAXEL; SCHIFF BASE; UNCLASSIFIED DRUG; WATER; MICELLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIODEGRADABILITY; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG RELEASE; DRUG UPTAKE; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MICELLE; NANOENCAPSULATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; HEPG2 CELL LINE; MCF 7 CELL LINE; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL CULTURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; HEP G2 CELLS; HUMANS; MCF-7 CELLS; MICELLES; MOLECULAR STRUCTURE; NANOPARTICLES; PACLITAXEL; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84892656401 PISSN: 09277765 EISSN: 18734367 Source Type: Journal
DOI: 10.1016/j.colsurfb.2013.12.051 Document Type: Article

Times cited : (38)

References (36)

1
- 72149093782
- Moreno A.A., Perez E.A. Clin. Ther. 2009, 31:1619.
- (2009) Clin. Ther. , vol.31 , pp. 1619
- Moreno, A.A.¹ Perez, E.A.²

2
- 42949158252
- Piccart-Gebhart M.J., Burzykowski T., Buyse M., et al. J. Clin. Oncol. 2008, 20:1980.
- (2008) J. Clin. Oncol. , vol.20 , pp. 1980
- Piccart-Gebhart, M.J.¹ Burzykowski, T.² Buyse, M.³

3
- 0029786845
- Gehl J., Boesgaard M., Paaske T., et al. Ann. Oncol. 1996, 7:687.
- (1996) Ann. Oncol. , vol.7 , pp. 687
- Gehl, J.¹ Boesgaard, M.² Paaske, T.³

4
- 0028348480
- Fornari F.A., Randolph J.K., Yalowich J.C., et al. Mol. Pharmacol. 1994, 45:649.
- (1994) Mol. Pharmacol. , vol.45 , pp. 649
- Fornari, F.A.¹ Randolph, J.K.² Yalowich, J.C.³

5
- 0038216623
- Abal M., Andreu J.M., Barasoain I. Curr. Cancer Drug Targets 2003, 3:193.
- (2003) Curr. Cancer Drug Targets , vol.3 , pp. 193
- Abal, M.¹ Andreu, J.M.² Barasoain, I.³

6
- 59349083179
- Jia J., Zhu F., Ma X., et al. Nat. Rev. Drug Discov. 2009, 8:111.
- (2009) Nat. Rev. Drug Discov. , vol.8 , pp. 111
- Jia, J.¹ Zhu, F.² Ma, X.³

7
- 34247260411
- Chuu J.J., Liu J.M., Tsou M.H., et al. J. Biomed. Sci. 2007, 14:233.
- (2007) J. Biomed. Sci. , vol.14 , pp. 233
- Chuu, J.J.¹ Liu, J.M.² Tsou, M.H.³

8
- 74049119820
- Jin C., Li H., He Y., et al. J. Cancer Res. Clin. Oncol. 2010, 136:267.
- (2010) J. Cancer Res. Clin. Oncol. , vol.136 , pp. 267
- Jin, C.¹ Li, H.² He, Y.³

9
- 84892641889
- Sherif Y.S., Tawfeeg A.N., Mouied A. J. Biochem. Mol. Toxicol. 2004, 18:78.
- (2004) J. Biochem. Mol. Toxicol. , vol.18 , pp. 78
- Sherif, Y.S.¹ Tawfeeg, A.N.² Mouied, A.³

10
- 0028051587
- Sledge G.J., Robert N., Sparano J.A., et al. Semin. Oncol. 1994, 21:15.
- (1994) Semin. Oncol. , vol.21 , pp. 15
- Sledge, G.J.¹ Robert, N.² Sparano, J.A.³

11
- 0028806664
- Sledge G.J. Semin. Oncol. 1995, 22:123.
- (1995) Semin. Oncol. , vol.22 , pp. 123
- Sledge, G.J.¹

12
- 70349978292
- Greco F., Vicent M.J. Adv. Drug Deliv. Rev. 2009, 61:1203.
- (2009) Adv. Drug Deliv. Rev. , vol.61 , pp. 1203
- Greco, F.¹ Vicent, M.J.²

13
- 84869168479
- Cao P., Bae Y. Future Oncol. 2012, 8:1471.
- (2012) Future Oncol. , vol.8 , pp. 1471
- Cao, P.¹ Bae, Y.²

14
- 79961050017
- Santosh A., Che-Ming J.H., Liangfang Z. Mol. Pharm. 2011, 8:1401.
- (2011) Mol. Pharm. , vol.8 , pp. 1401
- Santosh, A.¹ Che-Ming, J.H.² Liangfang, Z.³

15
- 84862830732
- Hu C.M., Zhang L. Biochem. Pharmacol. 2012, 83:1104.
- (2012) Biochem. Pharmacol. , vol.83 , pp. 1104
- Hu, C.M.¹ Zhang, L.²

16
- 84858638371
- Frank C., Taeghwan H., Vincent M.R. Chem. Soc. Rev. 2012, 41:2537.
- (2012) Chem. Soc. Rev. , vol.41 , pp. 2537
- Frank, C.¹ Taeghwan, H.² Vincent, M.R.³

17
- 78651498281
- Singh S. J. Nanosci. Nanotechnol. 2010, 10:7906.
- (2010) J. Nanosci. Nanotechnol. , vol.10 , pp. 7906
- Singh, S.¹

18
- 14644396096
- Moghimi S.M., Hunter A.C., Murray J.C. FASEB J. 2005, 19:311.
- (2005) FASEB J. , vol.19 , pp. 311
- Moghimi, S.M.¹ Hunter, A.C.² Murray, J.C.³

19
- 84892635635
- Desale S.S., Cohen S.M., Zhao Y., et al. J. Control Release 2013, 13:00245.
- (2013) J. Control Release , vol.13 , pp. 00245
- Desale, S.S.¹ Cohen, S.M.² Zhao, Y.³

20
- 84866748279
- Shi S., Zhu X., Guo Q., et al. Int. J. Nanomed. 2012, 7:1749.
- (2012) Int. J. Nanomed. , vol.7 , pp. 1749
- Shi, S.¹ Zhu, X.² Guo, Q.³

21
- 28444473061
- Park E.K., Kim S.Y., Lee S.B., et al. J. Control Release 2005, 109:158.
- (2005) J. Control Release , vol.109 , pp. 158
- Park, E.K.¹ Kim, S.Y.² Lee, S.B.³

22
- 0037027471
- Chin D.L., Lum B.L., Sikic B.I. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002, 779:259.
- (2002) J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. , vol.779 , pp. 259
- Chin, D.L.¹ Lum, B.L.² Sikic, B.I.³

23
- 57049140409
- Danhier F., Lecouturier N., Vroman B., JérÔme C., Marchand-Brynaert J., Feron O., Préat V. J. Control. Release 2009, 113:11.
- (2009) J. Control. Release , vol.113 , pp. 11
- Danhier, F.¹ Lecouturier, N.² Vroman, B.³ JérÔme, C.⁴ Marchand-Brynaert, J.⁵ Feron, O.⁶ Préat, V.⁷

24
- 84934444135
- Meerloo J., Kaspers G.J., Cloos J. Methods Mol. Biol. 2011, 731:237.
- (2011) Methods Mol. Biol. , vol.731 , pp. 237
- Meerloo, J.¹ Kaspers, G.J.² Cloos, J.³

25
- 65949120534
- Dong X., Mattingly C.A., Tseng M.T., et al. Cancer Res. 2009, 69:3918.
- (2009) Cancer Res. , vol.69 , pp. 3918
- Dong, X.¹ Mattingly, C.A.² Tseng, M.T.³

26
- 33645232498
- Villeneuve D.J., Hembruff S.L., Veitch Z., et al. Breast Cancer Res. Treat. 2006, 96:17.
- (2006) Breast Cancer Res. Treat. , vol.96 , pp. 17
- Villeneuve, D.J.¹ Hembruff, S.L.² Veitch, Z.³

27
- 84862236222
- Ren T., Liu Q., Lu H., et al. J. Mater. Chem. 2012, 12:12329.
- (2012) J. Mater. Chem. , vol.12 , pp. 12329
- Ren, T.¹ Liu, Q.² Lu, H.³

28
- 84878703830
- Theodora K.C., Theoni K.G. J. Mater. Chem. B 2013, 1:3002.
- (2013) J. Mater. Chem. B , vol.1 , pp. 3002
- Theodora, K.C.¹ Theoni, K.G.²

29
- 77957684578
- Feng X., Lv F., Liu L., et al. ACS Appl. Mater. Interfaces 2010, 2:2429.
- (2010) ACS Appl. Mater. Interfaces , vol.2 , pp. 2429
- Feng, X.¹ Lv, F.² Liu, L.³

30
- 80052386569
- Wang H., Zhao Y., Wu Y., Hu Y.L., Nan K., Nie G., Chen H. Biomaterials 2011, 32:8281.
- (2011) Biomaterials , vol.32 , pp. 8281
- Wang, H.¹ Zhao, Y.² Wu, Y.³ Hu, Y.L.⁴ Nan, K.⁵ Nie, G.⁶ Chen, H.⁷

31
- 84875191130
- Wang H., Wu Y., Zhao R., Nie G. Adv. Mater. 2013, 25:1616.
- (2013) Adv. Mater. , vol.25 , pp. 1616
- Wang, H.¹ Wu, Y.² Zhao, R.³ Nie, G.⁴

32
- 1542291181
- Feng S.S., Mu L., Win K.Y., et al. Curr. Med. Chem. 2004, 11:413.
- (2004) Curr. Med. Chem. , vol.11 , pp. 413
- Feng, S.S.¹ Mu, L.² Win, K.Y.³

33
- 84887043389
- Nie S.Y., Sun Y., Lin W.J., Wu W.S., Guo X.D., Qian Y., Zhang L.J. J. Phys. Chem. B 2013, 117:13688.
- (2013) J. Phys. Chem. B , vol.117 , pp. 13688
- Nie, S.Y.¹ Sun, Y.² Lin, W.J.³ Wu, W.S.⁴ Guo, X.D.⁵ Qian, Y.⁶ Zhang, L.J.⁷

34
- 0142105948
- Kohane D.S., Anderson D.G., Yu C., et al. Pharm. Res. 2003, 20:1533.
- (2003) Pharm. Res. , vol.20 , pp. 1533
- Kohane, D.S.¹ Anderson, D.G.² Yu, C.³

35
- 4344700337
- Edmund N., Brian E., Anthony D.M. Mol. Biol. Cell 2004, 15:4073.
- (2004) Mol. Biol. Cell , vol.15 , pp. 4073
- Edmund, N.¹ Brian, E.² Anthony, D.M.³

36
- 76549129820
- Ting-Chao C. Cancer Res. 2010, 70:440.
- (2010) Cancer Res. , vol.70 , pp. 440
- Ting-Chao, C.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.